Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1978-10-11
1980-02-05
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
424311, 424319, A61K 31215, A61K 31195
Patent
active
041873157
ABSTRACT:
N-Alkyl and N-cycloalkyloxamic acid derivatives are disclosed which inhibit glycolic acid oxidase and thus are useful in the treatment and prevention of calcium oxalate urolithiasis (kidney and bladder stone disease).
REFERENCES:
Schuman et al., Biochem-Biophys. Acta, 227, 521 (1971).
Liad et al., Arch. Biochem-Biophys. 154, 68 (1973).
Edmond et al., Brit. J. Pharmac. Chemother, 27, 415-426 (1966).
Stromberg, Material Protection, 4, 60-64 (1965).
Chemical Abstracts, 65:11156e (1966).
Cragoe, Jr. Edward J.
Novello Frederick C.
Saari Walfred S.
Merck & Co. , Inc.
Schenkman Leonard
Sudol, Jr. Michael C.
Westlake, Jr. Harry E.
LandOfFree
N-alkyl(and cycloalkyl)oxamic acid and derivatives as inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-alkyl(and cycloalkyl)oxamic acid and derivatives as inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-alkyl(and cycloalkyl)oxamic acid and derivatives as inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2180652